Résultats de recherche Affichage de 10 résultats sur 10 pour “cancer du sein”
CanPath partners with CIHI to develop a fuller picture of Canadians' health outcomes
…for Cancer Research and the University of Toronto’s Dalla Lana School of Public Health with national funding from the Canadian Partnership Against Cancer. To learn more, visit www.canpath.ca. About CIHI:…
Stage shifting by modifying the determinants of breast cancer stage at diagnosis: a simulation study
The researchers sought to understand how lifestyle factors influence the stage at which breast cancer is diagnosed. Using data from 492 participants in Alberta’s Tomorrow Project, they found that increasing…
Investigating the oral microbiome in retrospective and prospective cases of prostate, colon, and breast cancer
Salivary samples from the Atlantic Partnership for Tomorrow’s Health (PATH) project and Alberta’s Tomorrow Project (ATP) to examine the existence of prostate, colon, and breast cancer biomarkers in the human…
Five-year absolute risk estimates of colorectal cancer based on CCRAT model and polygenic risk scores: A validation study using the Quebec population-based cohort CARTaGENE
Cette étude visait à évaluer la performance prédictive de l’outil d’évaluation du risque de cancer colorectal parallèlement à trois scores de risque polygénique pour prédire l’apparition d’un cancer colorectal à un horizon de cinq ans. Utilisant les données de 6 747 participants à CARTaGENE, les chercheurs ont constaté que cet outil nécessiterait un meilleur calibrage avant son utilisation pratique au Québec.
Webinar on applying for Canadian Partnership for Tomorrow Project data and biosamples to support key questions in cancer research
The Canadian Institutes of Health Research (CIHR) has launched a funding opportunity to use data and biosamples from existing cohorts and databases to address key questions in cancer research. To…
Toenail arsenic species and metallome profiles associated with breast, cervical, prostate, and skin cancer prevalence in the Atlantic Partnership for Tomorrow’s Health cohort
…characterize the profiles of arsenic species and metallome in the toenails of four cancer groups, compare them to healthy participants, and assess potential associations between the profiles with cancer prevalence….
How Canadian data could help us understand cancer
What causes cancer and chronic diseases? The Canadian Partnership for Tomorrow Project (CPTP) is hoping to gather enough evidence to answer that question — at least, in about 30 years or so….
Comment les données canadiennes pourraient nous aider à comprendre le cancer
Qu’est-ce qui cause le cancer et les maladies chroniques? Le Partenariat canadien pour la santé de demain (CanPath) espère rassembler suffisamment de preuves pour répondre à cette question – du moins, d’ici…
Predictors of colorectal cancer screening: a comparison of men and women.
L’étude a révélé que le dépistage du cancer colorectal chez les adultes à risque moyen était peu fréquent dans cet échantillon, accusant un retard sur le dépistage d’autres cancers. Les auteurs ont fait valoir que des programmes éducatifs pourraient inciter plus de gens à se soumettre à un dépistage.
Development and external validation of partial proportional odds risk prediction models for cancer stage at diagnosis among males and females in Canada
This study examined health patterns in Alberta’s Tomorrow Project participants before cancer diagnosis to find factors related to cancers caught early versus late. The researchers found factors then tested them…